ALSN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ALSN is not a clean buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock looks technically strong and is trading near its recent highs, but the latest quarter showed weakening revenue and earnings, and analysts remain split with a mixed but mostly Neutral-to-mixed Wall Street view. Since there is no strong proprietary buy signal today and no recent news catalyst, my direct call is to hold and wait rather than buy aggressively at this level.
ALSN’s technical setup is bullish. Price closed at 133.5, above the pivot at 132.13 and just below resistance R1 at 136.324. The moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200), which supports an uptrend. MACD histogram is positive and expanding, confirming momentum. RSI_6 at 63.668 is constructive but not overextended. Overall, the trend is up, but the stock is already approaching resistance, so upside from here looks more limited in the near term.
["Bullish technical trend with SMA_5 > SMA_20 > SMA_200", "Positive and expanding MACD histogram", "Analyst price target moves have trended higher in recent months, with Citi and Oppenheimer both raising targets", "Upcoming QMAR 2026 earnings on 2026-05-04 After Hours could act as a catalyst", "No recent negative news in the past week"]
["Latest quarter showed revenue down 7.41% YoY, net income down 43.43% YoY, and EPS down 41.71% YoY", "No recent news flow to create an immediate fresh catalyst", "Stock is near resistance at 136.324, limiting short-term upside", "Analyst view is not uniformly bullish; Citi remains Neutral and BofA is Underperform", "No recent congress trading data or influential insider/politician buying signal"]
In Q4 2025, Allison Transmission showed weaker top- and bottom-line growth. Revenue fell to $737M, down 7.41% YoY, while net income dropped to $99M, down 43.43% YoY, and EPS declined 41.71% YoY to 1.16. The positive note is gross margin improved to 48.03%, up 2.50% YoY, indicating better pricing/cost control even as demand softened. Overall, the latest quarter was operationally mixed but financially weaker on earnings.
Recent analyst action has been mixed but slightly improving on price targets. Citi raised its target to $135 from $130 and kept Neutral. Earlier, Citi also lifted its target to $130 from $110 while staying Neutral. BofA raised its target to $95 from $92 but kept Underperform, citing choppy end markets and weaker-than-expected 2026 outlook. Oppenheimer raised its target to $135 from $115 and kept Outperform, pointing to strong EBITDA performance and improving off-highway prospects. Wall Street pros and cons: bulls like margin resilience, cost controls, and off-highway/infrastructure exposure; bears focus on choppy end markets, weaker revenue/EPS trends, and cautious near-term outlook.
